VHL and nonpapillary renal cell carcinoma: Here, the analysis of metabolic gene expression profiles revealed that the loss of the von Hippel-Lindau (VHL) tumor suppressor gene and key metabolic genes located next to VHL results in a ccRCC-specific set of genetic aberrations shaping a unique metabolic reprogramming which supports cancer progression [88].